Background: Earlier, we have identified PTOV1 as a novel interactome of PIN1 in PC-3 cells.
2 negative) cases have poor prognosis and highlight the need to explore the new molecular targets for breast cancer therapy.
Protein-Protein interactions (PPIs) transduce many important cellular functions and their dysregulation can cause diseases. The expression of aberrant proteins seems to enhance their tumor-promoting function due to their interaction with their partners in the cancerous state (5).
Identification of cancer enabling PPI hubs that maintain or amplify the cell transformation potential in cancer is one of the major therapeutic strategies in the battle against cancer (6).
PIN1 is an established oncogene that regulates the fate of phosphorylated protein catalyzing cis-trans isomerization. PIN1 is overexpressed in breast cancer and mediates its function via RAS signaling, increasing the transcription of c-Jun towards Cyclin D1 (7). Our previous study showed that PIN1 interacts with the novel protein Prostate Tumor Overexpressed 1(PTOV1) in PC-3 cells (8). PTOV1 is a 46 kDa protein with a tandem duplication of two repeated homology blocks of the sequence of 151 and 147 amino acids closely related to each other, located on the 19q 13.3-13.4 chromosome. Chromosome 19 harbors a large number of genes modulated by androgens including PIN1. The Overexpression of PTOV1 in prostate cancer may be due to the cumulative effect of genes residing on chromosome 19. The immunocytochemical analysis of PC-3 cell showed that PTOV1 is located in the cytoplasm close to the nucleus (9). Overexpression of PTOV1 causes the expression of c-Jun both total and in phosphorylated form in prostate cancer cells. PTOV1 interacts with RACK1 to bind with 40s ribosomes during translation initiation stage (10).
The purpose of our study was to reveal how PTOV1 and PIN1 coordinate to drive breast cancer progression, towards this end we used siRNA silencing approach to find out the change in expression profile of various oncogenic signal molecules at transcription and translation levels in MDA-MB-231 cells. Targeting this complex can contribute to autophagy and apoptosis induced cell death increasing the efficacy of the therapeutic approach against breast cancer.
Methods

Cell line, reagents, and antibodies
MDA-MB-231and MCF-7 breast cancer cell lines were purchased from NCCS, Pune, India.
Lipofectamine RNAiMAX and Opti-MEM media were obtained from Invitrogen Corp (Carlsbad, CA, USA). siRNAs were purchased from Qiagen (Hilden, Germany). SYBR Green was obtained from Bio-Rad (Hercules, California). Cell culture media, trypsin, and antibiotics were purchased from HiMedia (France). Antibodies were purchased from Santa Cruz Biotechnology (Dallas, Texas, USA), and Cloud-Clone Corp. (Houston, USA). Cell Titer-Glo reagent was obtained from Promega Corp (Madison, Wisconsin, USA). 3 
Cell culture
MDA-MB-231and MCF-7 cells were cultured in the L-15 medium and Dulbecco's Modified Eagle's medium (DMEM) respectively containing 10% FBS (Fetal bovine serum), Penicillin (100 unit/ml) and Streptomycin (100µg/ml). The cell culture was incubated at 37°C in humidified air containing 5% CO 2 .
Transfection
2-3ᵡ10 5 cells/well were seeded in 6 well plates one day before siRNA transfection. 25 nM of each siRNA was mixed with 100 µl Opti-MEM media. Similarly, the complex of Lipofectamine RNAi max (4 µl/each well) and Opti-MEM (100 µl) was mixed well and incubated for 5 minutes at room temperature. After that siRNA and Lipofectamine RNAiMAX complexes in Opti-MEM were mixed in 1:1 proportion and incubated for 25 minutes at room temperature. Cells were transfected with siRNA complexes and incubated at 37°C for 72 hours.
Cell viability assay
Cell viability was accessed by Cell Titer Glo (CTG) assay according to the manufacturer's protocol. Briefly, MDAMB-231 cells were seeded in 96 well white culture plates at a density of 1000 cells/well in 180 µl of the medium. 20 µl of siRNA complexes of SCR, PIN1, and PTOV1 was prepared as mentioned above and reversely transfected in cells. Cells were incubated at 37°C, 5% CO 2 for 96 hours. Following incubation, 100 µl of media was added to each well and treated with 100 µl of CTG reagent and kept on a shaker for 2 minutes. The plates were kept at room temperature for 10 minutes to stabilize the luminescence signal.
Luminescence was measured using microtiter plate ELISA reader (Bio Tek, Winooski, Vermont, USA).
We also, estimated the cell viability of MCF-7 by Crystal Violet assay after transfecting cells with scramble, PIN1 and PTOV1 siRNA. Briefly, 3000 cells/well were seeded in 96 well plates and on the next day cells were transfected with the siRNAs for 72 hours. Following incubation, cells were stained with 0.4% crystal violet in 50% methanol for 30 mins. After which wells were washed with tap water to remove the excess dye. 100 µl of methanol was put in each well to dissolve the dye attached to cells on a rocker for 20 mins. Then the absorbance was recorded using microtiter plate ELISA reader.
Colony formation assay
MDA-MB-231 and MCF-7 cells were transfected with siRNAs for 48 hours. Then, they were collected and 1000 cells/well were seeded in 6 well plates. Cells were allowed to grow for two 4 weeks till the colonies could be observed. The colonies were fixed with 3.7% formaldehyde for 30 minutes and stained with 0.4% crystal violet. Cells were washed with DPBS to remove excess dye. The plate was left to air dry and the colonies were counted using Image J software.
Wound healing assay
3ᵡ10 5 cells/well were seeded in 6 well plates and transfected with siRNAs. A scratch was made with 10 µl tip on the monolayer of cells at 72 hours post-transfection. Then they were washed with DPBS to remove detached cells. The images were captured using an inverted microscope at 0, 6, and 12 hours. The area of the wound was calculated using Image J software 2.6 Cell cycle analysis 2.5ᵡ10 5 cells/well were seeded in 6 well plates one day before transfection. After which they were transfected with siRNAs and incubated for 48 hours. Following the incubation, cells were harvested and fixed with ice-cold 70% ethanol and kept overnight at 4°C. Next, they were washed with DPBS, collected, and centrifuged at 1500 rpm for 5 minutes, after which they treated with RNase A (50 U/ml) for 1 hour and stained with Propidium iodide (PI) (20 μg/ml).
Cells were further subjected to cell cycle analysis by flow cytometry (BD FACS Verse ™).
Hoechst staining
1.5ᵡ10 5 cells were seeded in 6 well plates. Next day, cells were transfected with siRNAs and incubated for 72 hours. After which they were stained with Hoechst 33342 stain (2µg) and kept in the dark for 15 minutes. Next, they were washed with DPBS and the images were captured using Nikon fluorescent microscope.
Measurement of the intracellular ROS production
Intracellular ROS generation was detected using fluoroprobe CM-H2DCFDA (Invitrogen).
1.5ᵡ10 5 cells were seeded in 6 well plates and transfected with siRNAs for 72 hours. Cells were treated with 10 µM CM-H2DCFDA and kept in the dark at 37⁰C for 30 minutes. Then, they were stained with Hoechst 33342 and incubated for 15 minutes in the dark at room temperature.
The wells were washed with DPBS and the images were captured using a fluorescence microscope.
RNA extraction, cDNA preparation, and real time PCR
2ᵡ10 5 cells were seeded in 6 well plates, transfected with siRNAs and incubated for 72 hours.
Then cells were harvested for RNA isolation using TRIzol lysis reagent following the manufacturer's protocol. 2µg of RNA was used for cDNA synthesis using RevertAid First strand cDNA synthesis kit (Thermo Fisher Scientific). Real time PCR was carried out using 5 iTaq SYBR green mix (Biorad) in ABI 700, (Invitrogen). PCR cycle condition was as shown below.
Hold stage 95°c (10min), PCR Stage (40 cycles) 95°c (15 sec),60°c (1min) and melt curve stage 95°c (15 sec),60°c (1min),95°c (15 sec). Sequences of primers for Real Time PCR are; PIN1 forward primer sequence 5'-TTTGAAGACGCCTCGTTTGC-3', reverse primer sequence 5'-GTGCGGAGGATGATGTGGAT-3', PTOV1 forward primer sequence 5'-AGACACTGAAGAGCCTGTGC-3', reverse primer sequence 5'-CGTTGACAAAGTTGCCCTGG-3', p21 forward primer sequence 5'CTGCCCAAGCTCTACCTTCC-3', reverse primer sequence 5'- 
Western blotting
2ᵡ10 5 cells were cultured in 6 well plates. Next day, cells were transfected with siRNAs and incubated for 72 hours. Following incubation, cells were washed twice with ice-cold DPBS, and the cell lysate was prepared using sodium dodecyl sulphate (SDS) lysis buffer. The samples were heated for 5 minutes at 100°C in a dry bath, run on SDS-PAGE, and then transferred to PVDF membrane (100 volts, 1 hour). The membranes were incubated with 5% skim milk in Tris buffer saline with 0.1% Tween20 (TBST) for 2 hours at room temperature. The blots were further incubated with primary antibodies and kept overnight at 4°C on a rocker. Then the blots were washed 5 times with TBST and probed with horseradish peroxidase (HRP) conjugated secondary antibodies. The blots were exposed to X-ray film in the dark using enhanced chemiluminescence (ECL, Biorad). β actin was used as a loading control.
Co-Immunoprecipitation
The MDA-MB-231 cells were washed with cold PBS 2 times and and collected in PBS using a scrapper. Cells were centrifuged at 1000 rpm for 5 minutes. Cells were lysed in lysis buffer (50 mM Tris (pH 7.5), 5mM EDTA, 150 mM NaCl, 1 mM dithiothreitol, 0.01% Nonidet P-40, 0.2 mM phenylmethylsulfonyl fluoride, and 1X protease inhibitor mixture). Cells were sonicated for 10 seconds. Cells were again centrifuged for 15,000 rpm for 20 minutes at 4C.The supernatant was collected in an Eppendorf tube. 50μl of lysate was collected for input.
Remaining cell lysate was divided into two equal parts in 2 Eppendorf tube and made 1 ml using lysis buffer and labelled as Pin1 IP and normal rabbit IgG. The lysates were incubated with 2 μg of PIN1 and normal rabbit IgG in respective tubes at 4C with gentle rolling for 12-24 hours. On the next day, homogenous solution of magnetic beads was taken in two Eppendorf tubes and placed in a magnet. The supernatant was thrown. The lysates containing antibody complex were incubated with the beads for 1hour at 4C with gentle rolling. Again, the tubes were placed in the magnet and the supernatant was thrown. 
Statistical Analysis
Results are represented as a mean ± standard deviation. The level of significance between scramble (control) groups and the tests (PIN1 and PTOV1 siRNA treated) groups have been calculated by ONE WAY ANOVA and students's t-test. P < 0.05 was considered statistically significant. *, **, *** represents P< 0.05, 0.01 and 0.001 respectively.
Results
Silencing of PTOV1 and PIN1 suppresses the cell viability of MDA-MB-231 cells.
Cells were knockdown for PIN1 and PTOV1 genes by transfecting with siRNAs and incubated for 96 hours. 
Silencing of PTOV1 and PIN1 inhibits colony formation of MDA-MB-231 cells
To study the long-term effect of the silencing of PIN1 and PTOV1 on cell proliferative potential, we performed colonogenic assay which is associated with tumor formation in vivo (11). Briefly, cells were transfected with siRNAs for 48 hours, collected, and 1000 cells per well were seeded in 6 well plates. Cells were allowed to grow for 14 days. The number and size of colonies were significantly inhibited in PIN1 and PTOV1 knockdown sample as compared to scramble (p< 0.001) ( Figure 1B ). Individual colonies were counted using Image J software and densitometry analysis was done ( Figure 1C ). Thus, silencing of both genes inhibited the proliferation and colony formation of MDA-MB-231 cells. As shown in Figure   S1 . B &C, similar effect has been seen in MCF-7 cells with PIN1 and PTOV1 knock down by siRNA transfection. colony numbers and size in PIN1 and PTOV1 knockdown cells were significantly inhibited as compared to scramble .
Silencing of PTOV1 and PIN1 attenuates the migratory potential of MDA-MB-231 cells
The migratory behavior of a cell is an important parameter in studying the invasive and metastatic potential following the treatment. Wound healing assay is a conventional technique to study the migratory behavior of a cell (12). In our experiment, we made a scratch on the monolayer of cells previously transfected with the above-mentioned siRNAs. The images were captured at 0, 6, and 12 hours using an inverted microscope. We observed that cell migration was significantly attenuated in PIN1 and PTOV1 knockdown samples as compared to scramble ( Figure 1D ). Quantitative analysis of the wound area using Image J software showed significant difference between scramble and PIN1 and PTOV1 knockdown cells at 12hr (p< 0.05) ( Figure   1E ). These results suggested that both the genes might be crucial for the migration of cells. In similar manner, we studied migration potential of MCF-7 cells and found that migration was significantly inhibited in 24 and 48 hours after knocking down of PIN1 and PTOV1 as shown in Figure S1 . D and E. Thus, the result showed both PIN1 and PTOV1 genes are important for migration of MCF-7 cells. 
Silencing of
Silencing of PTOV1 and PIN1 induces nuclear condensation and initiation of apoptosis.
Nuclear condensation is the phenotype which indicates the initiation of apoptosis (13, 14).
Cells were transfected with the siRNAs for 72 hours and then stained with Hoechst 33342 dye.
The phase contrast images showed that the morphology of cells in PIN1 and PTOV1 samples were altered and not healthy as compared to untransfected and scramble and the DAPI images showed that the nuclear size was reduced in knockdown samples compared to scramble and untransfected cells. These results showed that silencing of both the genes might initiate cells towards apoptosis ( Figure 3A) .
Silencing of PTOV1and PIN1 elevates the intracellular ROS production
The level of ROS production has a determinant role on the behavior of cells. In the context of cancer, it possesses both an oncogenic property sustaining the proliferation of cancer cells as well as a tumor suppressor property when there is an aberrant increase in ROS due to any kind 9 of stimuli (15). Thus, the search for the genes modulating the redox status of a cancer cell can be a good anti-cancer strategy (16). As shown in Figure 3B , there was an increased production of ROS in PIN1 and PTOV1 silenced cells compared to scramble siRNA and non-transfected cells. Bar graph in right panel showed the quantification of ROS production by counting number of cells producing ROS out of total number of cells. Thus, our results revealed that downregulation of PIN1 and PTOV1 modulates the redox status of MDA-MB-231 cells enhancing their death significantly.
Silencing of PTOV1 and PIN1 initiates the cell death of MDA-MB-231 cells by inducing apoptosis.
To study the cell death mechanism initiated by knockdown of PIN1 and PTOV1, western blot analysis was carried out to check the expression of apoptosis-related genes. There was inhibition of anti-apoptotic Bcl-2 ( Figure 4A ), Bcl-xL ( Figure 4B ), and up-regulation of proapoptotic BAX ( Figure 4C ). These results clearly suggested that inhibition of both the genes initiate cell death through apoptosis. Also, we found the enhanced expression of autophagy markers LC3 ( Figure 4D ) and Beclin-1( Figure 4E ) after PTOV1 (Beclin-1 was unaffected by PIN1 knockdown figure 4F ), These results demonstrated that PTOV1 silencing also induced cell death by autophagy.
Silencing of PTOV1 and PIN1 shares regulatory networks and affect diverse cellular
functions at the transcriptional level.
mRNA expression of the genes affecting cell proliferation, cell cycle, apoptosis, and metastasis was studied after knockdown of cells with siRNAs for 72 hours. As shown in Figure 5A & B, the bar graph showed the relative expression of mRNAs in PIN1 and PTOV1 siRNA transfected samples compared to scramble samples respectively. The value for the expression of genes in scramble sample is considered to be 1.00. Study of the regulation of various genes by PIN1 and PTOV1 at transcriptional level mentioned in Table No . 1, we realized that knockdown of both the genes shared similar expression profile and affect the major functions required for cancer cell progression. The expression was downregulated for cell proliferation, cell cycle, and metastasis-related genes while cell cycle inhibitor p27 and p21 were upregulated in PIN1 and PTOV1 siRNA transfected samples respectively. Our results suggest that a wide range of genes which are involved in cell proliferation, cell cycle, metastasis, and apoptosis are regulated by PIN1 and PTOV1 at the transcriptional level significantly.
3.9 PTOV1 interacts with PIN1 and share the regulatory network of multiple oncogenic signaling pathways at the translational level.
We have already reported that PIN1 interacts with PTOV1 in PC-3 cells (8). We have performed Co-IP with PIN1 IP to see the interaction of PIN1 and PTOV1 in MDA-MB-231 cells. As shown in figure 6A . (i) PTOV1 is enrich in PIN1 complex. Furthermore, we analyzed the common regulatory network of both the genes at the protein level, western blots were performed after transfecting cells with siRNAs for 72 hours. Knockdown of PIN1 inhibited the expression of PTOV1 but there was no change in the expression of PIN1 protein level with PTOV1 knockdown ( Figure 6A. ii & iii). Cells were also treated with Juglone (5µM), a PIN1
inhibitor, for 48 hours. The expression of both PIN1 and PTOV1 was inhibited significantly ( Figure 6A . iv). These results suggested that PTOV1 contributes for PIN1 mediated MDA-MB-231 cell proliferation. Moreover, the overexpression of PIN1 with PIN1-XPRESS increased the expression of PTOV1 more than two folds ( Figure 6A . v). These results supported our previous finding that PTOV1 and PIN1 interaction play an important role in cancer cell proliferation (8).
PIN1 and PTOV1 silencing inhibited the expression of β-catenin ( Figure 6B . i) which is involved regulates the expression of both Cyclin D1 and c-Myc ( Figure 6B . ii, & iii). We have earlier shown that PTOV1 regulates the PIN1 substrate c-Jun phosphorylation (8). These data supported our finding that PIN1 and PTOV1 contribute to oncogenesis of breast cancer cells targeting Cyclin D1 and c-Myc expression. PTOV1 interacts with the RACK1 to bind with the 40s ribosomes during translation initiation (10). RACK1 has earlier been shown to be the regulator of cell signaling, migration and ribosomal functioning (29-31). In our experiment, we found that PIN1 and PTOV1 knockdown suppressed the expression of RACK1. Thus, our results showed that PIN1 is required for PTOV1 mediated translational machinery through RACK1 ( Figure 6C . i). We also checked the expression of Cyclin B1, a G2/M transition regulatory protein and found that its expression was inhibited by siRNAs ( Figure 6C . ii). This result supported the role of PTOV1 in cell cycle regulation. The expression of MAPK8 (c-Jun N-terminal kinase) which phosphorylates c-Jun ( Figure 6C . iii) was also inhibited. ERK is already known to be the substrate of PIN1 (32). Decreased phosphorylated ERK by PTOV1 downregulation suggested that PIN1 and PTOV1 share the similar expression profile of MAPK pathway ( Figure 6C . iv). These results showed the mechanisms of the PIN1 and PTOV1 cascade involvement in breast cancer cell proliferation via β-catenin and MAPK pathway.
Discussion
PTOV1 expression predicts the poor prognosis in multiple tumors (9, 10, 33, 34). Studies on the interacting partners and the proteins that share the close regulatory network with PTOV1 has helped to elucidate the cellular functions. Our study has taken the first step in establishing the functional relationship between PIN1 and PTOV1. On the assumption that functionally related genes show a similar expression profile and could fall in the same pathway, in our study we have used the RNAi mediated approach to knock down the genes and explore the different parameters of cell transformation such as cell proliferation, migration, cell cycle, autophagy and apoptosis that are required to draw the correlation between the genes. Our earlier finding showed that PTOV1 physically interacts with PIN1. PTOV1 also regulates the expression of It can be speculated that PTOV1 may be required for the PIN1 mediated phosphorylation of ERK. RACK1 has earlier been shown to interact with PTOV1 which regulates translation of c-Jun in PC-3 cells (10). Our previous finding showed that PTOV1 is a novel regulator of PIN1 mediated c-Jun phosphorylation and PTOV1 interacts with PIN1 (8). Here, we have shown that RACK1 is regulated by both PIN1 and PTOV1. Summing up all these results, it can be deduced that PTOV1 is contributing for PIN1 mediated cell transformation.
In conclusion, we have demonstrated that PIN1 and PTOV1 show similar expression profiles 
